Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“and is especially prevalent in North America.6,138,139”
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Self-citation(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus
Bannerman, T. L., Hancock, G. A., Tenover, F. C., & Miller, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.551-555.1995 · Cited by 550
Self-citationCharacterization of glycopeptide-resistant enterococci from U.S. hospitals
Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2311 · Cited by 395
Self-citationApplication of pulsed-field gel electrophoresis to molecular epidemiology
Maslow, J. N. (1993) · Medical Entomology and Zoology · Cited by 382
Research works printed but not linked: 7
- 1997, MMWR Morb Mortal Wkly Rep, 46, 624
- 2000, MMWR Morb Mortal Wkly Rep, 48, 1165
- 2002, MMWR Morb Mortal Wkly Rep, 51, 565
- Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:264-82.
- 2001, MMWR Morb Mortal Wkly Rep, 50, 1
- 1995, MMWR Morb Mortal Wkly Rep, 44, 1
- 1997, MMWR Morb Mortal Wkly Rep, 46, 626
Cited by
Items 601–700 of 1,000
Eguia, J. M., Liu, C., Moore, M. R., Wrone, E. M., Pont, J., Gerberding, J. L., & Chambers, H. F. “. (2005) · Clinical Infectious Diseases · doi:10.1086/429906 · Cited by 19
“VRSA contain the vanA gene complex found in vancomycin-resistant enterococci; their resistance is due to modification of the cell wall target of glycopeptides [5].”
BackgroundCare of the critically ill patient with advanced chronic kidney disease or end-stage renal disease
Hotchkiss, J. R., & Palevsky, P. M. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32835a1c59 · Cited by 18
Antibiotic resistance in Staphylococcus aureus colonising the intestines of Swedish infants
Lindberg, E., Adlerberth, I., & Wold, A. E. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01002.x · Cited by 18
“aureus isolates were identified that carried the vanA gene conferring resistance to vancomycin [4–6].”
BackgroundGoodarzi, N. N., Bolourchi, N., Fereshteh, S., Shirazi, A. S., Pourmand, M. R., & Badmasti, F. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105149 · Cited by 18
Wang, X. L., Wang, R., Zhang, Z., Zhang, G., Jin, Z., Shen, R., Du, D., & Tang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114341 · Cited by 18
Acquisition of vancomycin-resistant enterococci in internal medicine wards
Cohen, M. J., Adler, A., Block, C., Gross, I., Minster, N., Roval, V., Tchakirov, R., Moses, A. E., & Benenson, S. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.04.260 · Cited by 18
Basri, D. F., Zin, N. M., Bakar, N. S., Rahmat, F., & Mohtar, M. (2008) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2008.131.136 · Cited by 18
Wright, M., Hebden, J. N., Harris, A. D., Shanholtz, C. B., Standiford, H. C., Furuno, J. P., & Perencevich, E. N. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502370 · Cited by 22
Dialysis patient empowerment: what, why, and how.
Schatell, D., & Witten, B. (2005) · PubMed · Cited by 18
Surgical Site Infections and Antimicrobial Prophylaxis
Talbot, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00318-0 · Cited by 18
Glycopeptide resistance: Links with inorganic phosphate metabolism and cell envelope stress
Santos‐Beneit, F., Ordóñez-Robles, M., & Martín, J. F. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.017 · Cited by 18
Treatment and prevention of enterococcal infections – alternative and experimental approaches
Koch, S., Hufnagel, M., & Hüebner, J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.9.1519 · Cited by 21
“In addition, enterococci can transfer resistance determinants to other more virulent bacteria, for example, staphylococci [6], which further increases the pathogenic importance of enterococci.”
BackgroundStaphylococcus aureus resistente a vancomicina.
Rodríguez, C. A., & Vesga, Ó. (2005) · Biomédica · doi:10.7705/biomedica.v25i4.1384 · Cited by 28
Obajuluwa, A. F., Olayinka, B. O., Adeshina, G., Onaolapo, J. A., & Afolabi-Balogun, N. B. (2015) · African Journal of Microbiology Research · doi:10.5897/ajmr2015.7547 · Cited by 17
Blechman, S. E., & Wright, E. S. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012422 · Cited by 24
The Enterococcus faecalis Exoproteome: Identification and Temporal Regulation by Fsr
Shankar, J., Walker, R. G., Ward, D., & Horsburgh, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033450 · Cited by 18
“Of these pathogens, Enterococcus faecalis is prominent due to the frequency of disease and its implication in antibiotic resistance transfer to Staphylococcus aureus and Listeria species [3–6].”
BackgroundLoza, E., Morosini, M. I., Pascual, Á., Tubau, F., Alcalá, J., Liñares, J., Hernández, J. R., Baquero, F., Perea, E. J., Martín, R., et al. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)72776-9 · Cited by 17
Harshman, D. K., Rao, B. M., McLain, J. E., Watts, G. S., & Yoon, J. (2015) · Science Advances · doi:10.1126/sciadv.1400061 · Cited by 18
“Tn 1546 has transconjugated from enterococci to MRSA on at least 12 independent clinical occasions ( 3 , 8 – 10 ), resulting in vancomycin-resistant S. aureus (VRSA) ( 11 ).”
BackgroundAntibacterial and Structural Properties and Printability of Starch/Clay/Polyethylene Composite Films
Pirooz, M., Navarchian, A. H., & Emtiazi, G. (2017) · Journal of Polymers and the Environment · doi:10.1007/s10924-017-1056-8 · Cited by 17
Nailor, M. D., & Sobel, J. D. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.03.011 · Cited by 21
The real vancomycin-resistant Staphylococcus aureus has arrived
Tenover, F. C. (2005) · Clinical Microbiology Newsletter · doi:10.1016/s0196-4399(05)80005-4 · Cited by 17
Self-citationHan, S. H., Chin, B. S., Lee, H. S., Jeong, S. J., Choi, H. K., Kim, C. K., Kim, C. O., Yong, D., Choi, J. Y., Song, Y. G., et al. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/593957 · Cited by 19
Kaya, M., Kaya, G. Ş., Gürsan, N., Kıreçcı, E., Dayı, E., & Gündoğdu, B. (2011) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.tripleo.2011.03.032 · Cited by 17
Serotyping of DutchStaphylococcus aureusstrains from carriage and infection
Melles∗, D. C., Taylor, K. L., Fattom, A., & van Belkum, A. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00376.x · Cited by 22
“However, the emergence of the vancomycin intermediate strains (VISA) followed by the isolation of a truly vancomycin-resistant S. aureus, that probably acquired the vanA gene from Enterococcus, has become a reality (CDC, 2002; Chang et al., 2003).”
BackgroundTice, A. D., & Rehm, S. J. (2010) · Clinical Infectious Diseases · doi:10.1086/653517 · Cited by 18
Farrell, D. J. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31827559a3 · Cited by 20
Wound‐Healing Properties of Chitosan and Its Use in Wound Dressing Biopharmaceuticals
Denis, T. G. S., Dai, T., Huang, Y., & Hamblin, M. R. (2012) · Wiley eBooks · doi:10.1002/9781119962977.ch22 · Cited by 22
Management of diabetic foot infections in an era of increasing microbial resistance
Nelson, S. B. (2009) · Current Infectious Disease Reports · doi:10.1007/s11908-009-0053-z · Cited by 21
Test results: characterising the antimicrobial activity of daptomycin
Wiedemann, B. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01625.x · Cited by 18
Overview of Antibiotic Use and Resistance: Setting the Stage for Tigecycline
Zinner, S. H. (2005) · Clinical Infectious Diseases · doi:10.1086/431670 · Cited by 20
Antibiotics for treatment of resistant gram-positive coccal infections
Al-Tatari, H., Abdel‐Haq, N., Chearskul, P., & Asmar, B. I. (2006) · The Indian Journal of Pediatrics · doi:10.1007/bf02825827 · Cited by 18
Yang, Q., Zhang, M., Tu, Z., Sun, Y., Zhao, B., Cheng, Z., Chen, L., Zhong, Z., Ye, Y., & Xia, Y. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13326-9 · Cited by 17
Rani, N. N. I. M., Hussein, Z. M., Mustapa, F., Azhari, H., Sekar, M., Chen, X. Y., & Amin, M. C. I. M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.021 · Cited by 23
Clark, E. G., Kumar, A., Langote, A., Lapinsky, S. E., Dodek, P., Kramer, A. H., Wood, G., Bagshaw, S. M., Wood, K., Gurka, D., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4147-9 · Cited by 16
“These results reflect the large, previously documented burden of antimicrobial resistance that can be broadly found among the chronic dialysis population [48–50].”
Resultispd guidelines/ReCOMMendA Ti Ons
Cullis, B., Abdelraheem, M. B., Abrahams, G., Balbi, A. L., Cruz, D. N., Frishberg, Y., Koch, V. H. K., McCulloch, M., Numanoğlu, A., Nourse, P. J., et al. (2014) · Cited by 16
Yang, L., Cai, C., Feng, Q., Shi, Y., Zuo, Q., Yang, H., Jing, H., Wei, C., Zhuang, Y., Zou, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep20929 · Cited by 16
Sudhakar, C. (2012) · InTech eBooks · doi:10.5772/2251 · Cited by 17
Evolution and Taxonomy of Staphylococci
Mathema, B., Mediavilla, J. R., Chen, L., & Kreiswirth, B. N. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch3 · Cited by 28
Santos‐Beneit, F., Fernández‐Martínez, L. T., Rodríguez‐García, A., Martín-Martín, S., Ordóñez-Robles, M., Yagüe, P., Manteca, Á., & Martı́n, J. F. (2014) · Future Microbiology · doi:10.2217/fmb.14.21 · Cited by 16
Vaudaux, P. E., Fleury, B., Gjinovci, A., Huggler, E., Bento, M., & Lew, D. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01612-08 · Cited by 17
Novel antibiotics for the treatment ofStaphylococcus aureus
Ohlsen, K. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.26 · Cited by 23
Clinical management of diabetic foot infection: diagnostics, therapeutics and the future
Matthews, P. C., Berendt, A. R., & Lipsky, B. A. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.1.117 · Cited by 16
Vouillamoz, J., Entenza, J. M., Hohl, P., & Moreillon, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4322-4327.2004 · Cited by 16
“The organism proved capable of accumulating resistance mechanisms to virtually all clinically available compounds, including the entire beta-lactam family, the recent anti-gram-positive quinolones, and the streptogramin and oxazolidinone families, as well as nonexperimental last-resort drugs such as glycopeptides (4,…”
BackgroundEisner, A., Gorkiewicz, G., Feierl, G., Leitner, E., Köfer, J., Kessler, H. H., & Marth, E. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.04.001 · Cited by 16
“Moreover, glycopeptide-resistant enterococci (GRE) are able to transfer glycopeptide resistance determinants located on mobile genetic elements to other pathogens such as methicillinresistant Staphylococcus aureus (Chang et al., 2003; Whitener et al., 2004).”
BackgroundGlycopeptide resistant Staphylococcus
Witte, W. (2004) · Journal of Veterinary Medicine Series B · doi:10.1111/j.1439-0450.2004.00774.x · Cited by 16
Emergence and Spread of Antimicrobial-Resistant Pathogens in an Era of Globalization
Senok, A. C., Botta, G. A., & Soge, O. O. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/286703 · Cited by 21
Berreta, A., Baumgardner, R. M., & Kopper, J. J. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05114-1 · Cited by 15
New therapy options for MRSA with respiratory infection/pneumonia
Ramírez, P., Fernández‐Barat, L., & Torres, A. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283509cfa · Cited by 17
Gutman, J. Z. G. (2015) · Journal of Spine · doi:10.4172/2165-7939.1000202 · Cited by 19
From Natural Products to Drugs
Biondi, S., Chugunova, E., & Panunzio, M. (2016) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63749-9.00008-6 · Cited by 15
Girijan, S. K., & Pillai, D. (2021) · Journal of Water and Health · doi:10.2166/wh.2021.117 · Cited by 15
Barriere, S. L. (2010) · Future Microbiology · doi:10.2217/fmb.10.138 · Cited by 15
“aureus strains with reduced susceptibility to vancomycin, as demonstrated by increasing minimum inhibi tory concentration (MIC) values [15].”
BackgroundCharacteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report
Jakovac, S., Bojić, E. F., Avdić, M., Tutiš, B., Ostojić, M., & Hukić, M. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0355 · Cited by 15
“12 13–15 This points to the need for surveillance methods that are capable of detecting the presence of resistance genes.”
Antimicrobial and Insecticidal Activities of n-Butanol Extracts from Some Streptomyces Isolates
Obeidat, M., Abu-Romman, S. M., Odat, N., Haddad, M. A., Al-Abbadi, A. A., & Hawari, A. D. (2017) · Research Journal of Microbiology · doi:10.3923/jm.2017.218.228 · Cited by 15
Antimicrobial therapy ofStaphylococcus aureusbloodstream infection
Tacconelli, E., & Cataldo, M. A. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.15.2505 · Cited by 17
“(2007) 8(15) Staphylococcus aureus (VRSA) strain (MIC ≥ 32 μ g/ml) was isolated in Michigan and was followed by another three cases in the US [9] .”
MethodKhan, F. A. K., Patil, R., Shinde, D. B., & Sangshetti, J. N. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12817 · Cited by 15
Daum, R. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00115-8 · Cited by 16
Lepelletier, D., Perron, S., Huguenin, H., Picard, M., Bémer, P., Caillon, J., Juvin, M.-E., & Drugeon, H. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502368 · Cited by 17
Multilocus sequence typing: el marcador molecular de la era de Internet
Vázquez, J. A., & Berrón, S. (2004) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(04)73045-1 · Cited by 15
Adeyemi, F. M., Oyedara, O. O., Yusuf-Omoloye, N. A., Ajigbewu, O. H., Ndaji, O. L., Adegbite-Badmus, M. K., Olumakinde, T. S., & Oluokun, T. E. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03660-3 · Cited by 16
Guan, D., Chen, F., Shi, W. K., Lan, L., & Huang, W. (2023) · ChemMedChem · doi:10.1002/cmdc.202200708 · Cited by 14
Chen, F.-J., Lauderdale, T.-L. Y., Wang, L.-S., & Huang, I. (2013) · Genome Announcements · doi:10.1128/genomea.01011-13 · Cited by 14
Yang, Q., Li, X., Jia, P., Giske, C. G., Kahlmeter, G., Turnidge, J. D., Yu, Y., Lv, Y., Wang, M., Sun, Z., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa414 · Cited by 15
Lowell, G. S., & Daum, R. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50121-8 · Cited by 15
An antibacterial hydroxy fusidic acid analogue from Acremonium crotocinigenum
Evans, L., Hedger, J. N., Brayford, D., Stavri, M., Smith, E. C. J., O’Donnell, G., Gray, A. I., Griffith, G. W., & Gibbons, S. (2006) · Phytochemistry · doi:10.1016/j.phytochem.2006.06.033 · Cited by 14
Community-Associated Methicillin-Resistant Staphylococcus aureus
Crawford, S. E., Boyle‐Vavra, S., & Daum, R. S. (2014) · ASM Press eBooks · doi:10.1128/9781555815585.ch9 · Cited by 14
Lee, J. C., Greenwich, J. L., Zhanel, G. G., Han, X., Cumming, A., Saward, L. L., & McLoughlin, R. M. (2010) · Infection and Immunity · doi:10.1128/iai.01364-09 · Cited by 13
“In many cases their target organisms have undergone evolutionarily adaptations and have become resistant to the effects of these powerful drugs (1, 6).”
BackgroundWu, X., Wang, C., He, L., Xu, H., Jing, C., Chen, Y., Deng, J., Lin, A., Deng, H., Cai, H., et al. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04084-0 · Cited by 14
“aureus (VRSA) infections in neonates, which were firstly reported in adults in 1996 and 2002 [26, 27].”
BackgroundShah, K. N., Shah, P. N., Agobe, F., Lovato, K., Gao, H., Ogun, O., Hoffman, C., Yabe-Gill, M., Chen, Q., Sweatt, J., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01515-22 · Cited by 13
Developing a mouse model of acute bacterial rhinosinusitis
Jin, M., Gu, Z., Bian, Z., Yang, J., Cao, Z.-W., Yu, X., & Genyan, G. (2011) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-011-1483-4 · Cited by 13
Fram, D., Castrucci, F. M., Taminato, M., Godoy-Martinez, P. C., Freitas, M. C. S., Belasco, A. G. S., Sesso, R., Pacheco-Silva, A., Pignatari, A. C. C., & Barbosa, D. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009007500023 · Cited by 13
Bello, O. O., Oyekanmi, E. O., Kelly, B. A., Mebude, O. O., & Bello, T. K. (2018) · International Annals of Science · doi:10.21467/ias.4.1.1-13 · Cited by 13
Bacteriologic analysis of bone biopsy from diabetic foot infections within a VA patient population
Parks, C. B., & Nguyen, S. (2018) · The Foot · doi:10.1016/j.foot.2018.10.004 · Cited by 13
Molecular Modification of Kex2 P1’ Site Enhances Expression and Druggability of Fungal Defensin
Jin, Y., Yang, N., Teng, D., Hao, Y., Mao, R., & Wang, J. (2023) · Antibiotics · doi:10.3390/antibiotics12040786 · Cited by 13
Infections in Immunocompromised Patients
Davidson, L. E., & Boucher, H. W. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch28 · Cited by 13
Mechanisms of Resistance of Bacteria Causing Ventilator-Associated Pneumonia
Szabó, D., Silveira, F. P., Fujitani, S., & Paterson, D. L. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.10.004 · Cited by 15
Prevention of infection in the intensive care unit
Bonten, M. J. M. (2004) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000139362.68445.11 · Cited by 14
Lewis, J. S., & Ellis, M. W. (2008) · Current Opinion in Internal Medicine · doi:10.1097/qco.0b013e3282f1beb8 · Cited by 14
Management of Diabetic Wounds: Expert Panel Consensus Statement
Hsia, H. C., Eriksson, E. K., Gurtner, G. C., Veves, A., Hamdy, O., Margolis, D. J., Armstrong, D. G., Lavery, L. A., Grice, E., Schultz, G., et al. (2025) · Advances in Wound Care · doi:10.1177/21621918251366586 · Cited by 16
Nanjundaswamy, S., Bindhu, S., Renganathan, R. R. A., Nagashree, S., Karthik, C. S., Mallu, P., & Ravishankar, V. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1968496 · Cited by 12
Quezada-Aguiluz, M., Aguayo-Reyes, A., Carrasco, C., Mejías, D., Saavedra, P., Mella-Montecinos, S., Opazo-Capurro, A., Bello‐Toledo, H., Munita, J. M., Hormazábal, J. C., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11081000 · Cited by 14
“However, the risk of dissemination of vancomycin-resistant or non-fully susceptible strains suggests that this antibiotic should be used sparingly [6].”
BackgroundZalegh, I., Bourhia, M., Zerouali, K., Katfy, K., Nayme, K., Khallouki, F., Benzaarate, I., Salamatullah, A. M., Alzahrani, A. A., Nafidi, H., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7467279 · Cited by 14
Mirzaie, S., Faghiri, I., Badouei, M. A., & Madani, S. A. (2022) · Veterinary Medicine and Science · doi:10.1002/vms3.1010 · Cited by 13
“In addition, VRE have been identified as a significant public health hazard because of van resistance genes transmission to other organisms especially MRSA to form vancomycin-resistant Staphylococcus aureus (VRSA) which is a pathogen that is difficult to treat (Chang et al., 2003).”
BackgroundDenis, O., Rodriguez‐Villalobos, H., & Struelens, M. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00003-8 · Cited by 12
Animal production systems as a selective environment for antibiotic resistance genes
Avguštin, J. A. (2012) · Acta agriculturae Slovenica · doi:10.2478/v10014-012-0008-1 · Cited by 12
“The immense importance of horizontal gene transfer of antibiotic resistance genes was subsequently demonstrated by an in-human transmission of the vanA gene from Enterococcus faecalis to Staphylococcus aureus resulting in vancomycin resistant S. aureus (vrSA) (Chang et al., 2003).”
BackgroundRecent development of antibacterial agents to combat drug-resistant Gram-positive bacteria
Konai, M. M., Barman, S., Acharya, Y., De, K., & Haldar, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00004-7 · Cited by 14
Aghazadeh, M. H., Rahbar, M., Monnavar, M. K., & Moghadam, F. S. (2009) · Pakistan Journal of Medical Sciences · Cited by 12
Vancomycin and Home Health Care
Fraser, T. G., Stosor, V., Wang, Q., Allen, A., & Zembower, T. (2005) · Emerging infectious diseases · doi:10.3201/eid1110.050336 · Cited by 12
Yang, S., Xu, L., Mierzwa, R., He, L., Terracciano, J., Patel, M. V., Gullo, V. P., Black, T. A., Zhao, W., Chan, T., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(04)00260-3 · Cited by 12
Gerhard, W. A., & Gunsch, C. K. (2020) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2019.110796 · Cited by 12
Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening
Kim, S. M., Escorbar, I., Lee, K., Fuchs, B. B., Mylonakis, E. E., & Kim, W. (2020) · The Journal of Microbiology · doi:10.1007/s12275-020-0163-8 · Cited by 14
The Epidemiology of Bacterial Resistance to Antimicrobial Agents
Tenover, F. C., & McGowan, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09843-2_4 · Cited by 12
Self-citationCan mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Wertheim, H. F. L., & Vos, M. D. (2005) · Critical Care · doi:10.1186/cc3720 · Cited by 12
Blakely, J., Sinkowitz‐Cochran, R. L., & Jarvis, W. R. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/505922 · Cited by 12
Hasman, H., Aarestrup, F. M., Dalsgaard, A., & Guardabassi, L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl033 · Cited by 12
“Resistance to this class of antibiotics was initially reported in enterococci in 1988(1) and has recently emerged in Staphylococcus aureus.(2,3) Six types of glycopeptide resistance operons have been described in enterococci (vanA to vanE and vanG).”
BackgroundThe State of the Science of health care epidemiology, infection control, and patient safety, 2004
Jarvis, W. R. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.09.001 · Cited by 13
Prevention of hospital-acquired pneumonia:
Bonten, M. J. M. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00068-0 · Cited by 12
Emerging drugs on methicillin-resistantStaphylococcus aureus
Liapikou, A., & Torres, A. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.813480 · Cited by 13
“Later, in 2002, the first van A-containing vancomycin-resistant S. aureus (VRSA) was isolated from a dialysis patient in Michigan, USA [14]; such isolates have since been detected throughout the world, although the incidence remains low.”
BackgroundBera, D., Pal, K., Ruidas, B., Mondal, D., Pal, S., Paul, B. K., Karmakar, P., Das, S., & Nandy, P. S. (2020) · Materials Today Communications · doi:10.1016/j.mtcomm.2020.101099 · Cited by 10
Inhibition of the Vancomycin Resistance in Staphylococcus aureus in Egypt Using Silver Nanoparticles
Salah, N. M., Saafan, A. E., Salem, E. H. M., Rabey, H. A. E., Alsieni, M., Alatawi, F. A., Alalawy, A. I., & Mohammed, A. B. A. (2022) · BioMed Research International · doi:10.1155/2022/7380147 · Cited by 11
“Isolates of vancomycin-resistant S . aureus have emerged in many parts of the world such as Japan [15], the United States [16], and India [17].”
Metadata
- Authors
- Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., Cardo, D., & Fridkin, S. K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Wayne State University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1342-1347
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068037991
- Semantic Scholar
- f0afb59f819a65ada63076a36807f63502c4437d
- Cited by
- 1,095
- References
- 18
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 24 · 2023: 28 · 2022: 24 · 2021: 35 · 2020: 29 · 2019: 39 · 2018: 28 · 2017: 29 · 2016: 28 · 2015: 55 · 2014: 54 · 2013: 51 · 2012: 65
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- vancomycin-resistant Staphylococcus aureus, vanA gene, vancomycin resistance, diabetes mellitus, peripheral vascular disease, foot ulcer, vancomycin-resistant Enterococcus faecalis, antibiotic resistance transfer, catheter-related infection
- MeSH terms
- Adult, Catheterization, Debridement, Female, Renal Dialysis, Humans, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Contact Tracing, Diabetic Foot, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.